Biogen And Eisai Expand Existing Collaboration Agreement To Develop And Commercialize Investigational for Alzheimer’s Disease Treatments
Eisai Co., Ltd. and Biogen Inc. announced that the companies have expanded their existing agreement to jointly develop and commercialize investigational Alzheimer's disease treatments....
ViiV Healthcare announces positive results from phase III BRIGHTE study of fostemsavir in HTE patients with HIV-1 infection
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced results from the phase III...
Bayer receives FDA approval for Xarelto 10 mg once daily for the extended treatment of venous thromboembolism
Bayer AG and its development partner Janssen Research & Development, LLC advise that the U.S. Food and Drug Administration (FDA) has approved a label...
Boehringer Ingelheim achieves major breakthrough in canine cardiology
Dogs suffering from cardiovascular disease and related clinical signs will officially have an opportunity for a better and longer life, according to significant research...
Servier and GeNeuro Announce Promising post hoc Analyses of Six-Month Data from CHANGE-MS Phase 2b Study at MSParis2017
Servier and GeNeuro announced post hoc analyses of 6-month data from the CHANGE-MS Phase 2b study of GNbAC1 for the treatment of patients with...
Eagle Pharmaceuticals Receives Tentative FDA Approval for PEMFEXY (Pemetrexed Injection) Ready-to-Dilute
Eagle Pharmaceuticals, Inc. announced that the United States Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s PEMFEXY™, a pemetrexed injection...
Sun Pharma announces US FDA approval for generic Coreg CR
Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has received final approval from US FDA for its Abbreviated New Drug...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...